Evidence map›Paper›PMID 36231341›Full record

ReviewInternational journal of environmental research and public health2022

Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.

Vicente F Gil-Guillen, Alejandro Balsa, Beatriz Bernárdez, Carmen Valdés Y Llorca, Emilio Márquez-Contreras, Juan de la Haba-Rodríguez, Jose M Castellano, Jesús Gómez-Martínez

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Vicente F Gil-GuillenDepartment of Clinical Medicine, Miguel Hernandez University, 03550 San Juan, Spain.
Alejandro BalsaRheumatology Department, La Paz University Hospital, 28046 Madrid, Spain.
Beatriz BernárdezDepartment of Oncologic Pharmacy, Santiago de Compostela University Hospital, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-6579-4903
Carmen Valdés Y LlorcaFuencarral Health Center, 28034 Madrid, Spain.
Emilio Márquez-ContrerasMolino de la Vega Health Center, 21002 Huelva, Spain.
Juan de la Haba-RodríguezThe Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Cordoba, Spain.
Jose M CastellanoCentro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.
Jesús Gómez-MartínezCommuniy Pharmacist, 08013 Barcelona, Spain.
Hospital Universitario La Paz · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESSpanish National Centre for Cardiovascular Research · ESUniversidade de Santiago de Compostela · ESUniversitat de Miguel Hernández d'Elx · ESUniversity of Alicante · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication adherence is directly associated with health outcomes. Adherence has been reviewed extensively; however, most studies provide a narrow scope of the problem, covering a specific disease or treatment. This project's objective was to identify risk factors for non-adherence in the fields of rheumatology, oncology, and cardiology as well as potential interventions to improve adherence and their association with the risk factors. The project was developed in three phases and carried out by a Steering Committee made up of experts from the fields of rheumatology, oncology, cardiology, general medicine, and hospital and community pharmacy. In phase 1, a bibliographic review was performed, and the articles/reviews were classified according to the authors' level of confidence in the results and their clinical relevance. In phase 2, 20 risk factors for non-adherence were identified from these articles/reviews and agreed upon in Steering Committee meetings. In phase 3, potential interventions for improving adherence were also identified and agreed upon. The results obtained show that adherence is a dynamic concept that can change throughout the course of the disease, the treatments, and other factors. Educational interventions are the most studied ones and have the highest level of confidence in the authors' opinion. Information and education are essential to improve adherence in all patients.

Indexed as

CardiologyRheumatologyHumansMedication AdherenceRisk Factorsadherencecardiologycompliancemedicationoncologyrheumatologytreatment

Identifiers

PMID36231341
PMCPMC9564665
OpenAlexW4297198458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.